Hallmarks of Cancer: New Dimensions
- PMID: 35022204
- DOI: 10.1158/2159-8290.CD-21-1059
Hallmarks of Cancer: New Dimensions
Abstract
The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. SIGNIFICANCE: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of "big data" about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.
©2021 American Association for Cancer Research.
Similar articles
-
Cancer hallmarks intersect with neuroscience in the tumor microenvironment.Cancer Cell. 2023 Mar 13;41(3):573-580. doi: 10.1016/j.ccell.2023.02.012. Cancer Cell. 2023. PMID: 36917953 Free PMC article. Review.
-
Updates of cancer hallmarks in patients with inborn errors of immunity.Curr Opin Allergy Clin Immunol. 2022 Dec 1;22(6):352-363. doi: 10.1097/ACI.0000000000000863. Epub 2022 Sep 21. Curr Opin Allergy Clin Immunol. 2022. PMID: 36165433 Free PMC article. Review.
-
Hallmarks of cancer-the new testament.Open Biol. 2021 Jan;11(1):200358. doi: 10.1098/rsob.200358. Epub 2021 Jan 20. Open Biol. 2021. PMID: 33465324 Free PMC article. Review.
-
Cancer Evolution: A Multifaceted Affair.Cancer Discov. 2024 Jan 12;14(1):36-48. doi: 10.1158/2159-8290.CD-23-0530. Cancer Discov. 2024. PMID: 38047596 Free PMC article.
-
Hallmarks of cancer: the next generation.Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013. Cell. 2011. PMID: 21376230 Review.
Cited by
-
Lactate secreted by glycolytic conjunctival melanoma cells attracts and polarizes macrophages to drive angiogenesis in zebrafish xenografts.Angiogenesis. 2024 Jun 6. doi: 10.1007/s10456-024-09930-y. Online ahead of print. Angiogenesis. 2024. PMID: 38842752
-
Current and future immunotherapeutic approaches in pancreatic cancer treatment.J Hematol Oncol. 2024 Jun 4;17(1):40. doi: 10.1186/s13045-024-01561-6. J Hematol Oncol. 2024. PMID: 38835055 Free PMC article. Review.
-
Identification and Validation of Nicotinamide Metabolism-Related Gene Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma.Onco Targets Ther. 2024 May 28;17:423-438. doi: 10.2147/OTT.S464709. eCollection 2024. Onco Targets Ther. 2024. PMID: 38827823 Free PMC article.
-
Tweety homolog 3 promotes colorectal cancer progression through mutual regulation of histone deacetylase 7.MedComm (2020). 2024 May 31;5(6):e576. doi: 10.1002/mco2.576. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38827027 Free PMC article.
-
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial.Nat Med. 2024 Jun 1. doi: 10.1038/s41591-024-03060-0. Online ahead of print. Nat Med. 2024. PMID: 38824244
References
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
-
- Yuan S, Norgard RJ, Stanger BZ. Cellular plasticity in cancer. Cancer Discov. 2019;9:837–51.
-
- Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009;457:608–11.
-
- Perekatt AO, Shah PP, Cheung S, Jariwala N, Wu A, Gandhi V, et al. SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium. Cancer Res. 2018;78:4878–90.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials